Shanghai, China Yitu Technology is the famous Corporate Investor, which was founded in 2012. The fund was located in Asia if to be more exact in China. The leading representative office of defined Corporate Investor is situated in the Shanghai.
The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2017.
We can highlight the next thriving fund investment areas, such as Manufacturing, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight ThinkForce.
The current fund was established by Lin Chenxi, Zhu Long.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Yitu Technology, startups are often financed by ZhenFund. The meaningful sponsors for the fund in investment in the same round are YF Capital (Yunfeng Capital), Sequoia Capital China, IDG Capital.
Related Funds
| Fund Name | Location |
| AmTRAN Technology | Taipei, Taiwan |
| Behrman Capital | New York, New York, United States |
| CB Health Ventures | Boston, Massachusetts, United States |
| CMU OFEF | Pennsylvania, Pittsburgh, United States |
| D2C Inc. | - |
| Encovox | - |
| Financial Information Technologies (Fintech) | Florida, Tampa, United States |
| Global Asia Partners | Central, Central Region, Singapore |
| HMA Capital Partners | Lansing, Michigan, United States |
| Hyperion Israel Venture Partners | - |
| Inflection Point Ventures | Gurgaon, Haryana, India |
| JapanTaxi | Japan, Tokyo |
| Jostens | Minneapolis, Minnesota, United States |
| Mengyun Yiruan | China, Shanghai |
| NT Asset | - |
| Prodea | Richardson, Texas, United States |
| Socogame | China, Shanghai |
| Wesfarmers | Australia, Perth, Western Australia |
| Yunsheng Touzi | China, Jinshan District |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ThinkForce | $69M | 15 Dec 2017 | Shanghai | ||
AccutarBio | 06 Dec 2017 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ThinkForce | $69M | 15 Dec 2017 | Shanghai | ||
AccutarBio | 06 Dec 2017 | Shanghai, China |
